Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Oruka Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ORKA alerts

About Thomas A. Keuer

Thomas A. Keuer is recorded as CEO at Oruka Therapeutics, Inc. (ORKA) since April 3, 2024. Oruka Therapeutics, Inc. reported in an 8-K filed April 4, 2024 that Thomas A. Keuer was appointed President and principal executive officer, effective April 3, 2024. The proxy statement of Oruka Therapeutics, Inc. reports total compensation of $853,520 for Thomas A. Keuer in fiscal 2024, including a base salary of $235,385. Disclosed compensation is on record for 7 fiscal years. Oruka Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Oruka Therapeutics, Inc. includes Lawrence Klein (CEO and Board Member), Samarth Kulkarni (Chairman and Board Member), C. Jeff Dekker (CFO) and 7 others.

“Effective as of April 3, 2024, the Board appointed Thomas A. Keuer, the Company’s Chief Operating Officer, to serve as ARCA’s President and principal executive officer.”
Oruka Therapeutics, Inc. Form 8-K, filed April 4, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Oruka Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Oruka Therapeutics, Inc. (ORKA) $235,385 $853,520
2023 Oruka Therapeutics, Inc. (ORKA) $340,000 $400,802
2022 Oruka Therapeutics, Inc. (ORKA) $340,000 $448,993
2021 Oruka Therapeutics, Inc. (ORKA) $338,577 $420,615
2020 Oruka Therapeutics, Inc. (ORKA) $284,937 $631,024
2019 Oruka Therapeutics, Inc. (ORKA) $283,189 $304,022
2018 Oruka Therapeutics, Inc. (ORKA) $303,000 $326,786

Recent activity